Transarterial Chemoembolization Combined with Apatinib for Treatment of Advanced Hepatocellular Carcinoma: Analysis of Survival and Prognostic Factors

[21] Gao Z(2018)Multicenter Phase II Clinical Trial of Sorafenib Combined with Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinomas (Barcelona Clinic Liver Cancer Stage C): STAB Study J Vasc Interv Radiol 29 1061-709

[22] Liang Q(2020)Assessment of efficacy and safety of the transcatheter arterial chemoembolization with or without apatinib in the treatment of large hepatocellular carcinoma Cancer Chemother Pharmacol 85 69-11

[23] Kong L(2020)Combining transcatheter arterial embolization with iodized oil containing Apatinib inhibits HCC growth and metastasis Sci Rep 10 2964-3967

[24] Du Y(2018)Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas Acad Radiol 25 423-e8

[25] Yang C(2017)Efficacy and safety of apatinib combined with transarterial chemoembolization for hepatocellular carcinoma with portal venous tumor thrombus: a retrospective study Oncotarget 8 100734-2998

[26] Qin S(2019)Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Apatinib in Patients with Advanced Hepatocellular Carcinoma Acad. Radiol 27 704-undefined

[27] Yang Z(2019)Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety Exp Mol Med 51 1-undefined

[28] Chen G(2011)Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma J Clin Oncol 29 3960-undefined

[29] Cui Y(2018)Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease Hypertension 71 e1-undefined

[30] Lu W(2008)Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma J Clin Oncol 26 2992-undefined

[21] Gao Z(2018)Multicenter Phase II Clinical Trial of Sorafenib Combined with Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinomas (Barcelona Clinic Liver Cancer Stage C): STAB Study J Vasc Interv Radiol 29 1061-709

[22] Liang Q(2020)Assessment of efficacy and safety of the transcatheter arterial chemoembolization with or without apatinib in the treatment of large hepatocellular carcinoma Cancer Chemother Pharmacol 85 69-11

[23] Kong L(2020)Combining transcatheter arterial embolization with iodized oil containing Apatinib inhibits HCC growth and metastasis Sci Rep 10 2964-3967

[24] Du Y(2018)Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas Acad Radiol 25 423-e8

[25] Yang C(2017)Efficacy and safety of apatinib combined with transarterial chemoembolization for hepatocellular carcinoma with portal venous tumor thrombus: a retrospective study Oncotarget 8 100734-2998

[26] Qin S(2019)Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Apatinib in Patients with Advanced Hepatocellular Carcinoma Acad. Radiol 27 704-undefined

[27] Yang Z(2019)Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety Exp Mol Med 51 1-undefined

[28] Chen G(2011)Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma J Clin Oncol 29 3960-undefined

[29] Cui Y(2018)Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease Hypertension 71 e1-undefined

[30] Lu W(2008)Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma J Clin Oncol 26 2992-undefined